Status:

COMPLETED

Prevention of Severe Anaemia in Gambian Children

Lead Sponsor:

London School of Hygiene and Tropical Medicine

Collaborating Sponsors:

Department of State for Health and Social Welfare, The Gambia

Conditions:

Anemia

Eligibility:

All Genders

3-9 years

Phase:

PHASE3

Brief Summary

Severe anaemia is a frequent cause of admission to hospitals in tropical Africa and about 10% of such children die. In endemic countries, anaemia has multiple causes such as nutritional deficiencies, ...

Detailed Description

Objectives 1. To assess the effectiveness of monthly prophylaxis with S/P on haematological recovery in children who have been treated for severe anaemia. 2. To measure compliance with the interventi...

Eligibility Criteria

Inclusion

  • Age: 3 months to 9 years.
  • Haemoglobin concentration 7g/dl on admission to hospital.
  • Residence within 30 km of the study centre and availability for the duration of the study period.
  • Informed consent to participate in the study given by the parent or guardian.

Exclusion

  • Simultaneous participation in any other trial.
  • Allergy to sulpha drugs.
  • Residence \> 30 km from the recruitment site.
  • Lack of consent.

Key Trial Info

Start Date :

May 1 2003

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2005

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT00131716

Start Date

May 1 2003

End Date

May 1 2005

Last Update

January 12 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Medical Research Council Laboratories,

Banjul, The Gambia